(Q45351330)

13 December 2017

title

Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus (English)

1 reference

Bifidobacterium adolescentis

13 December 2017

1 reference

object named as

Bifidobacterium adolescentis

1 reference

Do Kyung Lee

1

1 reference

13 December 2017

Joo Yeon Kang

2

1 reference

13 December 2017

Hea Soon Shin

3

1 reference

13 December 2017

Il Ho Park

4

1 reference

13 December 2017

Nam Joo Ha

5

1 reference

13 December 2017

publication date

9 May 2013

1 reference

Archives of Pharmacal Research

13 December 2017

published in

1 reference

13 December 2017

volume

36

1 reference

13 December 2017

issue

12

1 reference

13 December 2017

page(s)

1525-1532

1 reference

Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Drugs in development for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Probiotics and human health: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Global control of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

A cell culture assay for compounds which inhibit hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Probiotics and their fermented food products are beneficial for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Current treatment of chronic hepatitis B: benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Interferon-inducible antiviral effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Hypocholesterolemic effect of sonication-killed Bifidobacterium longum isolated from healthy adult Koreans in high cholesterol fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Probiotics can treat hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Trypan blue exclusion test of cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0141-3

10.1007/S12272-013-0141-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1053630811

0 references

1 reference